Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors.

Genes & Development
Gregory J Gores, Scott H Kaufmann

Abstract

Bcl-2, Bcl-x(L), Mcl-1, and A1 are the predominant anti-apoptotic members of the Bcl-2 family in somatic cells. Malignant B lymphocytes are critically dependent on Bcl-2 or Bcl-x(L) for survival. In contrast, a new study by Glaser and colleagues in the January 15, 2012, issue of Genes & Development (pp. 120-125) demonstrates that Mcl-1 is essential for development and survival of acute myelogenous leukemia cells. These results provide new impetus for the generation of selective Mcl-1 inhibitors.

References

Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K M KozopasR W Craig
Feb 19, 2005·Science·Joseph T OpfermanStanley J Korsmeyer
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan FröhlingRoss L Levine
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Nieng Yan, Yigong Shi
Dec 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Judith E KarpKenneth S Bauer
Apr 4, 2007·Oncogene·J L MottG J Gores
Apr 6, 2007·Cancer Research·Yun Dai, Steven Grant
Jul 31, 2007·Current Opinion in Immunology·Joseph T Opferman
Nov 28, 2007·Proceedings of the National Academy of Sciences of the United States of America·Mai NguyenGordon C Shore
Mar 14, 2008·Current Molecular Medicine·Matthew R Warr, Gordon C Shore
Jul 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·John R MillsJerry Pelletier
Sep 5, 2009·Cancer Biology & Therapy·Han LiuJames J D Hsieh
Oct 24, 2009·Blood·Ramiro GarzonCarlo M Croce
Dec 22, 2009·Nature·Martin SchwickartVishva M Dixit
Feb 19, 2010·Nature·Rameen BeroukhimMatthew Meyerson
Mar 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farhad RavandiHagop M Kantarjian
Jun 22, 2010·Nature Chemical Biology·Michelle L StewartLoren D Walensky
Nov 13, 2010·Molecular Cell·Evripidis GavathiotisLoren D Walensky
Jul 19, 2011·Developmental Cell·Jean-Claude Martinou, Richard J Youle
Aug 20, 2011·Expert Opinion on Investigational Drugs·Bridget A QuinnPaul B Fisher
Nov 1, 2011·Molecular Cell·Fabien LlambiDouglas R Green
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Loren D Walensky

❮ Previous
Next ❯

Citations

Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Dec 12, 2012·Cancer Research·Joachim C MertensGregory J Gores
Dec 26, 2015·Biochimica Et Biophysica Acta·Peter P RuvoloMichael Andreeff
May 15, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Parwathy ChandranManzoor Koyakutty
Mar 10, 2016·British Journal of Cancer·Michael ButterworthGerald M Cohen
Nov 30, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ming LiuJing Li
Sep 22, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Tao HuangHao Qian
May 21, 2014·Cancer Biology & Therapy·Kenichiro DoiHong-Gang Wang
Mar 4, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Ha-Na JungYong-Sik Kim
Oct 21, 2016·Apoptosis : an International Journal on Programmed Cell Death·Yuan-Chin LeeLong-Sen Chang
Dec 16, 2016·Science Translational Medicine·Gray R AndersonKris C Wood
Feb 1, 2017·Leukemia & Lymphoma·Prithviraj BoseMarina Konopleva
Apr 25, 2017·Expert Opinion on Therapeutic Targets·Su-Fern TanThomas P Loughran
May 19, 2017·PloS One·Denis O OkumuLee M Graves
Jul 9, 2013·Cell Death and Differentiation·S VaradarajanG M Cohen
Jun 21, 2013·Nature Reviews. Cancer·Philippe JuinMario Campone
Oct 21, 2017·Cell Death and Differentiation·Haiming DaiScott H Kaufmann
Oct 16, 2019·Oncology Letters·Qing Wang, Siguo Hao
May 9, 2014·The Journal of Biological Chemistry·Xiaming PangXu Luo
Sep 5, 2020·Molecular Carcinogenesis·Zina SarifJürgen Eberle
Jan 31, 2016·The Journal of Biological Chemistry·Sumera RizviGregory J Gores
May 26, 2018·Journal of Cellular Physiology·Anna De BlasioRiccardo Di Fiore
Jan 8, 2020·Cell Death and Differentiation·Viacheslav V SenichkinGelina S Kopeina
Nov 29, 2016·The Journal of Clinical Investigation·Mohamed ElgendySaverio Minucci
Apr 23, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaojia NiuYubin Ge
Oct 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rui WangYongkui Jing
Mar 2, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Sean M PostPeter P Ruvolo
Apr 23, 2021·Journal of Hematology & Oncology·Haolan WangYongheng Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.